M. Tenenhaus et al., SUPPLEMENTATION OF AN ELEMENTAL ENTERAL DIET WITH ALANYL-GLUTAMINE DECREASES BACTERIAL TRANSLOCATION IN BURNED MICE, Burns, 20(3), 1994, pp. 220-225
Citations number
NO
Categorie Soggetti
Dermatology & Venereal Diseases","Emergency Medicine & Critical Care
Although there are many reports of the importance of early enteral fee
ding in maintaining gastrointestinal integrity and preventing bacteria
l translocation ( BT) following burn injury, no diet has been shown cl
inically to protect the GI tract postburn. Several studies suggest tha
t glutamine (GLN) may benefit gut integrity following injury, shock an
d other stress. Unfortunately, the free amino acid GLN is unstable in
solution. Alanyl-glutamine (ALA-GLN), a soluble form of GLN, maintains
long-term stability in solution and could be supplemented to conventi
onal liquid enteral diets. We studied the effects of ALA-GLN supplemen
tation of the elemental diet Vivonex TEN on effecting BT in mice follo
wing 32 per cent TBSA full skin thickness burns. Groups A-D were burne
d. Group A (30 mice) was fed standard rodent chow, which contains extr
emely high (clinically non-useable) levels of protein. Group B (51 mic
e) was fasted 24 h, then fed chow 24 h. Group C (64 mice) was fed Vivo
nex TEN, and Group D (65 mice) received Vivonex TEN plus ALA-GLN (GLN
equivalent, 14 g/l). A control group (Group E) consisted of 22 normal
mice (no burn injury, chow diet). Mice were assessed for BT by sterile
harvesting and plating of mesenteric lymph node tissue, 48 h postburn
. Plates were considered positive if any bacterial growth was noted. N
on-burned mice exhibited no BT, while burn-fasted mice showed a 64.3 p
er cent incidence of BT (P = NS). Burned mice fed Vivonex TEN showed a
55.9 per cent rate of BT. Maximal protection against BT was afforded
by rodent chow (31.0 per cent BT, P = 0.0081). We also found a reduced
incidence of BT after supplementation of Vivonex TEN with ALA-GLN com
pared to burn-fasted animals (36.1 per cent vs 64.3 per cent BT, P = 0
.009), or compared to mice fed Vivonex TEN without supplemental ALA-GL
N (36.1 per cent vs 55.9 per cent BT, P = 0.046).